Literature DB >> 10319874

Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions.

S Engelender1, Z Kaminsky, X Guo, A H Sharp, R K Amaravi, J J Kleiderlein, R L Margolis, J C Troncoso, A A Lanahan, P F Worley, V L Dawson, T M Dawson, C A Ross.   

Abstract

Parkinson disease (PD) is a neurodegenerative disease characterized by tremor, bradykinesia, rigidity and postural instability. Post-mortem examination shows loss of neurons and Lewy bodies, which are cytoplasmic eosinophilic inclusions, in the substantia nigra and other brain regions. A few families have PD caused by mutations (A53T or A30P) in the gene SNCA (encoding alpha-synuclein). Alpha-synuclein is present in Lewy bodies of patients with sporadic PD, suggesting that alpha-synuclein may be involved in the pathogenesis of PD. It is unknown how alpha-synuclein contributes to the cellular and biochemical mechanisms of PD, and its normal functions and biochemical properties are poorly understood. To determine the protein-interaction partners of alpha-synuclein, we performed a yeast two-hybrid screen. We identified a novel interacting protein, which we term synphilin-1 (encoded by the gene SNCAIP). We found that alpha-synuclein interacts in vivo with synphilin-1 in neurons. Co-transfection of both proteins (but not control proteins) in HEK 293 cells yields cytoplasmic eosinophilic inclusions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10319874     DOI: 10.1038/8820

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  141 in total

1.  Synphilin-1-binding protein NUB1 is colocalized with nonfibrillar, proteinase K-resistant α-synuclein in presynapses in Lewy body disease.

Authors:  Kunikazu Tanji; Fumiaki Mori; Katsumi Kito; Akiyoshi Kakita; Junsei Mimura; Ken Itoh; Hitoshi Takahashi; Tetsu Kamitani; Koichi Wakabayashi
Journal:  J Neuropathol Exp Neurol       Date:  2011-10       Impact factor: 3.685

Review 2.  Rare genetic mutations shed light on the pathogenesis of Parkinson disease.

Authors:  Ted M Dawson; Valina L Dawson
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 3.  Genetically engineered mouse models of Parkinson's disease.

Authors:  Donna M Crabtree; Jianhua Zhang
Journal:  Brain Res Bull       Date:  2011-08-03       Impact factor: 4.077

Review 4.  Drug targets from genetics: α-synuclein.

Authors:  Karin M Danzer; Pamela J McLean
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

5.  Genome-wide DNA methylation profiling of peripheral blood mononuclear cells in irritable bowel syndrome.

Authors:  S Mahurkar; C Polytarchou; D Iliopoulos; C Pothoulakis; E A Mayer; L Chang
Journal:  Neurogastroenterol Motil       Date:  2015-12-16       Impact factor: 3.598

6.  Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy.

Authors:  K A Conway; S J Lee; J C Rochet; T T Ding; R E Williamson; P T Lansbury
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

7.  Mutation analysis of the seven in absentia homolog 1 (SIAH1) gene in Parkinson's disease.

Authors:  T Franck; R Krueger; D Woitalla; T Müller; S Engelender; O Riess
Journal:  J Neural Transm (Vienna)       Date:  2006-06-06       Impact factor: 3.575

8.  Dementia with Lewy bodies: no association of polymorphisms in the human synphilin gene.

Authors:  J Busby; K K O'Brien; A M Gibson; I G McKeith; R H Perry; J A Hardy; A B Singleton; C M Morris
Journal:  Neurogenetics       Date:  2004-12       Impact factor: 2.660

9.  Genome-wide scan linkage analysis for Parkinson's disease: the European genetic study of Parkinson's disease.

Authors:  M Martinez; A Brice; J R Vaughan; A Zimprich; M M B Breteler; G Meco; A Filla; M J Farrer; C Bétard; J Hardy; G De Michele; V Bonifati; B Oostra; T Gasser; N W Wood; A Dürr
Journal:  J Med Genet       Date:  2004-12       Impact factor: 6.318

10.  Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.

Authors:  Anne-Maria Poehler; Wei Xiang; Philipp Spitzer; Verena Elisabeth Luise May; Holger Meixner; Edward Rockenstein; Oldriska Chutna; Tiago Fleming Outeiro; Juergen Winkler; Eliezer Masliah; Jochen Klucken
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.